| FVC% predicted (%) | P for trend | ||
---|---|---|---|---|
Tertile 1 | Tertile 2 | Tertile 3 | ||
Men | ||||
 Range, % | > 100.6 | 87.3–100.6 | < 87.3 |  |
 Number of participants | 251 | 251 | 251 |  |
 Presence of arterial stiffness, n (%) | 168 (69.3) | 181 (72.1) | 208 (82.9) |  |
 Crude OR (95% CI) | 1.00 | 1.28 (0.87–1.87) | 2.39 (1.57–3.64)** | < 0.001 |
 Adjusted OR (95% CI) | 1.00 | 1.35 (0.86–2.11) | 2.18 (1.32–3.59)** | 0.002 |
 Presence of PAD, n (%) | 4 (1.6) | 6 (2.4) | 6 (2.4) |  |
 Crude OR (95% CI) | 1.00 | 1.51 (0.42–5.43) | 1.51 (0.42–5.43) | 0.54 |
 Adjusted OR (95% CI) | 1.00 | 1.46 (0.39–5.44) | 1.32 (0.35–5.04) | 0.69 |
Women | ||||
 Range, % | > 105.7 | 94.1–105.7 | < 94.1 |  |
 Number of participants | 258 | 258 | 259 |  |
 Presence of arterial stiffness, n (%) | 118 (45.7) | 139 (53.9) | 166 (64.1) |  |
 Crude OR (95% CI) | 1.00 | 1.39 (0.98–1.96) | 2.12 (1.49–3.01)** | < 0.001 |
 Adjusted OR (95% CI) | 1.00 | 1.14 (0.76–1.72) | 1.22 (0.79–1.89) | 0.36 |
 Presence of PAD, n (%) | 3 (1.2) | 3 (1.2) | 7 (2.7) |  |
 Crude OR (95% CI) | 1.00 | 1.00 (0.20–5.00) | 2.36 (0.60–9.23) | 0.18 |
 Adjusted OR (95% CI) | 1.00 | 0.70 (0.12–3.92) | 1.18 (0.24–5.87) | 0.82 |